Erythromycin enteric-coated capsules are anti-inflammatory drugs. Erythromycin enteric-coated capsules belong to the macrolide class of antibiotics and are used clinically to treat respiratory system infections, skin and soft tissue infections, genitourinary system infections, as well as rectal infections and oral infections caused by anaerobic bacteria. This drug reaches its peak blood concentration 2-3 hours after oral administration, is metabolized in the liver, and is excreted in the form of feces and urine. The main adverse reactions are gastrointestinal reactions manifested, nausea, vomiting, abdominal pain, diarrhea, etc. can occur after drug administration, the incidence of which is related to the size of the dose, as well as an increase in liver function enzymes. A small number of patients may experience allergic reactions such as drug fever, rash and eosinophilia.